Revvity | PKI - Current Liabilities



Revvity reported $671.81M in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Adcock Ingram Holdings ZAR 2.81B 279.84M Dec/2024
Agilent USD 1.89B 120M Jul/2025
Align Technology USD 2B 4.54M Jun/2025
Bio Techne USD 175.85M 6.64M Jun/2025
Bio-Rad Laboratories USD 548.9M 42.3M Jun/2025
Bruker USD 1.35B 2.5M Jun/2025
Celltrion KRW 3.4T 216.25B Mar/2025
Charles River Laboratories USD 1.08B 29.38M Jun/2025
Cspc Pharmaceutical CNY 9.63B 801.28M Dec/2024
Danaher USD 6.79B 147M Jun/2025
Dentsply International USD 1.17B 627M Jun/2025
Dianthus Therapeutics USD 20.09M 1.64M Jun/2025
Divis Laboratories Ltd 14.52B 1.61B Mar/2025
Edwards Lifesciences USD 1.39B 110.4M Mar/2025
Exact Sciences USD 521.93M 19.47M Jun/2025
Hologic USD 962.5M 27.2M Jun/2025
Illumina USD 1.46B 21M Jun/2025
Intuitive Surgical USD 2.21B 197.4M Jun/2025
IQVIA Holdings USD 7.57B 393M Jun/2025
Kangmei Pharma CNY 5.75B 64.58M Jun/2025
Knight Therapeutics CAD 118.15M 12.32M Sep/2024
Laboratorios Farma EUR 186.51M 29.86M Jun/2025
Laboratory Of America USD 2.72B 652.2M Jun/2025
Malin Corporation EUR 1000K 500K Dec/2024
Medical Developments International AUD 6.37M 3.17M Dec/2024
Mettler Toledo International USD 1.11B 42.8M Jun/2025
Myriad Genetics USD 151.1M 13M Mar/2025
Neuren Pharmaceuticals AUD 45.76M 36.79M Dec/2024
Organigram Holdings CAD 107.28M 38.32M Jun/2025
Pharma Mar EUR 87.78M 8.29M Jun/2025
Qiagen NV USD 1.13B 611.37M Jun/2025
Quest Diagnostics USD 2.02B 583M Jun/2025
Quidel USD 1.14B 94.9M Jun/2025
Repligen USD 152M 25.21M Mar/2025
Revvity USD 671.81M 23.63M Jun/2025
Sartorius EUR 1.55B 72.7M Jun/2025
Sino Biopharmaceutical CNY 19.56B 2.39B Dec/2024
Thermo Fisher Scientific USD 12.72B 456M Jun/2025
Tilray USD 278.52M 15.02M Nov/2024
Waters USD 1.02B 55.16M Jun/2025
Zz Pientze Pharmaceu 3.2B 878.89M Jun/2025